196 related articles for article (PubMed ID: 37311281)
1. Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications.
Chinnadurai RK; Khan N; Meghwanshi GK; Ponne S; Althobiti M; Kumar R
Biomed Pharmacother; 2023 Aug; 164():114996. PubMed ID: 37311281
[TBL] [Abstract][Full Text] [Related]
2. Anti-Cancer Peptides: Status and Future Prospects.
Ghaly G; Tallima H; Dabbish E; Badr ElDin N; Abd El-Rahman MK; Ibrahim MAA; Shoeib T
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770815
[TBL] [Abstract][Full Text] [Related]
3. Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
Alamdari-Palangi V; Jaberi KR; Shahverdi M; Naeimzadeh Y; Tajbakhsh A; Khajeh S; Razban V; Fallahi J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15249-15273. PubMed ID: 37581648
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy.
Min KA; Maharjan P; Ham S; Shin MC
Arch Pharm Res; 2018 Jun; 41(6):594-616. PubMed ID: 29804279
[TBL] [Abstract][Full Text] [Related]
6. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).
Chiangjong W; Chutipongtanate S; Hongeng S
Int J Oncol; 2020 Sep; 57(3):678-696. PubMed ID: 32705178
[TBL] [Abstract][Full Text] [Related]
7. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer.
Burger JA; Stewart DJ; Wald O; Peled A
Expert Rev Anticancer Ther; 2011 Apr; 11(4):621-30. PubMed ID: 21504328
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer peptide-based therapeutic strategies in solid tumors.
Karami Fath M; Babakhaniyan K; Zokaei M; Yaghoubian A; Akbari S; Khorsandi M; Soofi A; Nabi-Afjadi M; Zalpoor H; Jalalifar F; Azargoonjahromi A; Payandeh Z; Alagheband Bahrami A
Cell Mol Biol Lett; 2022 Apr; 27(1):33. PubMed ID: 35397496
[TBL] [Abstract][Full Text] [Related]
9. Anticancer peptides mechanisms, simple and complex.
Norouzi P; Mirmohammadi M; Houshdar Tehrani MH
Chem Biol Interact; 2022 Dec; 368():110194. PubMed ID: 36195187
[TBL] [Abstract][Full Text] [Related]
10. The Potential Use of Peptides in Cancer Treatment.
Yavari B; Mahjub R; Saidijam M; Raigani M; Soleimani M
Curr Protein Pept Sci; 2018; 19(8):759-770. PubMed ID: 29332577
[TBL] [Abstract][Full Text] [Related]
11. Bioactive cationic peptides as potential agents for breast cancer treatment.
Manrique-Moreno M; Santa-González GA; Gallego V
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34874400
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
13. Marine peptides in breast cancer: Therapeutic and mechanistic understanding.
Ahmed S; Mirzaei H; Aschner M; Khan A; Al-Harrasi A; Khan H
Biomed Pharmacother; 2021 Oct; 142():112038. PubMed ID: 34411915
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptides: a promising strategy for lung cancer drug discovery?
Zandsalimi F; Talaei S; Noormohammad Ahari M; Aghamiri S; Raee P; Roshanzamiri S; Yarian F; Bandehpour M; Zohrab Zadeh Z
Expert Opin Drug Discov; 2020 Nov; 15(11):1343-1354. PubMed ID: 32749935
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of marine peptides in malignant melanoma.
Ahmed S; Alam W; Alsharif KF; Aschner M; Alzahrani FM; Saso L; Khan H
Environ Res; 2023 Jun; 227():115771. PubMed ID: 36967001
[TBL] [Abstract][Full Text] [Related]
16. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
17. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
Zhang K; Yuan Q
J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
[TBL] [Abstract][Full Text] [Related]
18. Potential clinical applications of multi-functional milk proteins and peptides in cancer management.
Chen HY; Mollstedt O; Tsai MH; Kreider RB
Curr Med Chem; 2014; 21(21):2424-37. PubMed ID: 24524762
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
20. Venom Peptides: Improving Specificity in Cancer Therapy.
Mahadevappa R; Ma R; Kwok HF
Trends Cancer; 2017 Sep; 3(9):611-614. PubMed ID: 28867164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
